Funding for this research was provided by:
H2020 European Research Council (ERC StG 207777)
Science Foundation Ireland (16/FRL/3845, 14/TIDA/2291)
Health Research Board Ireland (HRA-POR-2015-1099)
Text and Data Mining valid from 2020-02-05
Received: 16 November 2019
Accepted: 20 January 2020
First Online: 5 February 2020
Ethics approval and consent to participate
: All work was approved by the Animal Care in Research Ethics Committee of the National University of Ireland, Galway, and conducted under licence from the Health Products Regulatory Authority, Ireland. Specific pathogen-free adult male Sprague-Dawley rats (Charles River Laboratories, Kent, UK) weighing between 300 and 450 g were used in all experiments.
: Not applicable.
: The patented xenogeneic-free (XF) culture supplement (WO2015121471 A1) was developed in the Regenerative Medicine Institute, National University of Ireland, Galway, Ireland.